Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III neoadjuvant chemotherapy trial in early breast cancer
ISRCTN72868621Phase 3Completed
- Sponsor
- The Institute of Cancer Research
- Start
- Jan 1998
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial in breast cancer comparing Vinorelbine + epirubicin, Vinorelbine + mitozantrone and Doxorubicin + cyclophosphamide (3 arms). Started Jan 1998; status: completed.
02
Drugs
vinorelbineepirubicinmitoxantronedoxorubicincyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN72868621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN72868621.